Molecular reorganization of endocannabinoid signalling in Alzheimer's disease - Wikidata - wikimedia - TriplyDB

Molecular reorganization of endocannabinoid signalling in Alzheimer's disease

Molecular reorganization of endocannabinoid signalling in Alzheimer's disease

http://www.wikidata.org/entity/Q34754667

about

The endocannabinoid system in normal and pathological brain ageing Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer's Disease Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice.The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels Endocannabinoids in synaptic plasticity and neuroprotection.Cannabinoid receptor 1 signaling in embryo neurodevelopment The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ an [¹²⁵I]SD-7015 reveals fine modalities of CB₁ cannabinoid receptor density in the prefrontal cortex during progression of Alzheimer's disease In vivo SPECT and ex vivo autoradiographic brain imaging of the novel selective CB1 receptor antagonist radioligand [125I]SD7015 in CB1 knock-out and wildtype mouse.Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease Intrinsic up-regulation of 2-AG favors an area specific neuronal survival in different in vitro models of neuronal damage.Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target.New ionization processes and applications for use in mass spectrometry.Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation.Endocannabinoid signalling and the deteriorating brain Exogenous and endogenous cannabinoids suppress inhibitory neurotransmission in the human neocortex Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease Cracking down on inhibition: selective removal of GABAergic interneurons from hippocampal networks Neuregulin-1 impairs the long-term depression of hippocampal inhibitory synapses by facilitating the degradation of endocannabinoid 2-AG CB1 cannabinoid receptors couple to focal adhesion kinase to control insulin release.Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease.Miswiring the brain: Δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway.The therapeutic potential of the endocannabinoid system for Alzheimer's disease.Group 1 metabotropic glutamate receptor function and its regulation of learning and memory in the aging brain The influence of cannabinoids on generic traits of neurodegeneration.Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic.Cannabinoids in late-onset Alzheimer's disease.Endocannabinoid system in neurodegenerative disorders.Targeted Lipidomics of Fontal Cortex and Plasma Diacylglycerols (DAG) in Mild Cognitive Impairment and Alzheimer's Disease: Validation of DAG Accumulation Early in the Pathophysiology of Alzheimer's Disease.Boosting brain glucose metabolism to fight neurodegeneration?A cell population that strongly expresses the CB1 cannabinoid receptor in the ependyma of the rat spinal cord.An automated method measures variability in P-glycoprotein and ABCG2 densities across brain regions and brain matter.Aging modifies the enzymatic activities involved in 2-arachidonoylglycerol metabolism.Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer's disease subjects.Neurochemical mapping of the human hippocampus reveals perisynaptic matrix around functional synapses in Alzheimer's disease.Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model.Anandamide Effects in a Streptozotocin-Induced Alzheimer's Disease-Like Sporadic Dementia in Rats

P2860

Q22242668-941EE845-0BC4-4F72-9EB5-765D798336DC Q26783325-1A68E80B-A547-4EB6-A288-C24D3A27E797 Q30506148-CA2C3221-7985-44F3-B720-AB5B4FC70542 Q33790150-50389F82-EE64-412C-8DC4-7C30B61AFC90 Q34084682-134C2361-526D-41A2-9130-DF736204888A Q34245609-BA2030A8-DF92-4A23-956E-81C48AB57362 Q34267133-A491B94D-6E39-49E5-9E5E-C26EC1263213 Q34269852-3CEFC088-A627-4650-9244-3D936072D08C Q34278947-73569186-2AB7-4722-9B8C-F7958EB967E0 Q34312272-5696F0A5-1F9A-476F-B359-C813F7A81804 Q34531690-61322E7B-FF96-4A04-857F-C280A602A7E4 Q34680801-57E77426-E138-46C3-A406-0B23442BA940 Q34863434-F9769A9D-BBEB-4729-9A9A-71CAF795D672 Q35592057-94B8B8E1-9294-4D48-AEF4-7655CD11AF1C Q35754490-13395B20-74A8-4FE1-812C-9836870BA0AC Q35837682-F9F50E26-AA65-48EA-8A2A-959F88A2F022 Q36300457-A87EF0A6-D056-4F52-BB4B-02CD5A59B414 Q36442881-D6288FF6-E355-4290-ADC3-A690F8E8AAC4 Q37093732-D15018A0-E0BF-45E9-AD67-8388D1E3B859 Q37179736-2D1A0410-9142-40AD-B7DD-308894BB5D07 Q37289307-B2FC575B-1633-4F64-A974-09517025C46D Q37553341-EB37B9AC-578A-4CE8-BF15-224248C7927C Q37723975-CA0685E9-4324-4F52-B689-213C822CFB96 Q37997020-489CED87-1BE5-47A2-BD8D-AA2C45BDF5C0 Q38054714-F53A4DB3-C9D0-45F9-8336-F05FB36AB99C Q38156518-4B3B8CCD-8D32-4601-9DA6-A982CD6E8674 Q38196398-3ECFA287-2FBF-40D2-9181-DC9C9EE1BFB6 Q38383508-8FCCA8A3-14A4-4160-8F5E-8F0832F69A2B Q39368845-E8FA9095-7402-4F3E-98C8-B70FF0901E8C Q41934251-37C1729A-BBAD-40DE-8494-ADCF2A2E5BF9 Q42314715-DC7F20D2-3C3E-405A-930C-1127B59D9C55 Q42509528-01E4FB1A-1FE7-436F-8BE2-BE570E44C2C1 Q47967419-A4F84406-18B3-40D5-9DE4-538FAF4A045D Q48229593-5CBDBFC9-7E70-476D-9D18-C3304E556C4D Q48237879-90D821B7-897B-4C86-857E-D6746D20B3EA Q48383180-A23B969F-4513-42B0-B5BD-12725CD900F8 Q50230005-1FDC9603-DE84-41D8-B854-469A4FC1E429 Q58552816-D08207EB-CE8C-4E90-8E71-D6EC649BB3C4

P2860

Molecular reorganization of endocannabinoid signalling in Alzheimer's disease

http://www.wikidata.org/entity/Q34754667

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Molecular reorganization of endocannabinoid signalling in Alzheimer's disease

@ast

Molecular reorganization of endocannabinoid signalling in Alzheimer's disease

@en

Molecular reorganization of endocannabinoid signalling in Alzheimer's disease

@nl

type

label

Molecular reorganization of endocannabinoid signalling in Alzheimer's disease

@ast

Molecular reorganization of endocannabinoid signalling in Alzheimer's disease

@en

Molecular reorganization of endocannabinoid signalling in Alzheimer's disease

@nl

prefLabel

Molecular reorganization of endocannabinoid signalling in Alzheimer's disease

@ast

Molecular reorganization of endocannabinoid signalling in Alzheimer's disease

@en

Molecular reorganization of endocannabinoid signalling in Alzheimer's disease

@nl

P1433

Q34754667-EA9CE24C-09A6-4334-A448-1355735261DD

P1476

Q34754667-0340B448-7C26-429B-8CDC-9E13DC5465E7

P2093

Q34754667-10B6EBB5-C6ED-4D5B-BFAD-EE35B26CBD04

Q34754667-1E70B8CE-8AAC-42F2-8446-E6E95765EEC8

Q34754667-B491D71E-7C4B-4F6D-A5F8-5F9264C227D1

Q34754667-B8225C6C-473F-44A6-AFC4-D345750054CE

Q34754667-BA55225F-4094-4238-BED8-5C9D6BC6F95D

Q34754667-E319B6DC-4095-4DCB-AE3C-1B5E5FF4FA8B

Q34754667-E63FAE1B-E721-4ED9-8496-A41BCFCBF357

P2860

Q34754667-0C69CD62-0EE5-4773-A876-F11E50317333

Q34754667-0C883DBD-AAC1-4140-8D4E-1792A93E0F26

Q34754667-0D5261E7-EDF1-43BE-8970-BEC5C59F2923

Q34754667-0ECA4E17-63C1-4D49-AD04-D419A0454336

Q34754667-10FCDAB5-5414-4F11-B21C-9143017C5F9F

Q34754667-1121218B-2775-4B1B-A24E-32A8ACEE048A

Q34754667-11E86CB1-E485-46F1-A70E-42C7F3FE6B2B

Q34754667-1B137D3C-8338-4E04-8675-16846D153DAE

Q34754667-1FA2FC57-DF87-4968-A05B-9F4DDA39B2FB

Q34754667-235B515B-17E9-4C3C-9084-07B6BE63960C

P304

Q34754667-7FB67194-1FB6-41D4-95A7-A12ED57B9EED

P31

Q34754667-58CE4498-CEB2-4AAA-B92B-EE972E1B8D10

P356

Q34754667-310704DB-6B9C-4AC0-8127-C976525A1C30

P407

Q34754667-AD377675-82F4-41B5-97BB-833EE2288218

P433

Q34754667-D2ECB36A-FCD4-42D4-ACDD-229F79116FA8

P478

Q34754667-A103A976-6856-45A3-B20E-9B8584B081BD

P50

Q34754667-04211099-ADE4-487E-A706-C247F9C6936C

Q34754667-098CDFD0-2BCB-47A6-A73B-41D798A0AC41

Q34754667-244CF9F9-6C98-4F5F-AEC0-62E94218929D

Q34754667-4AF4D1DC-D13A-4C7A-BF27-BDA37DD773C4

Q34754667-69B8D400-985F-408B-8810-2B1C689E248E

Q34754667-69DE6E5E-05EB-48C7-9F87-4E7543846269

Q34754667-D558EDA2-F3C3-44BA-BF68-7AD097D1F46E

Q34754667-E23A787B-938A-4369-B7E1-24258A059EF5

P577

Q34754667-B72DE081-0333-4F87-8586-3A2FC77C1312

P5875

Q34754667-D19EF661-06A0-4BEE-9D2E-CFD3193E428C

P698

Q34754667-4E39A8B2-919B-4CF2-97CC-2E2C79E1CED8

P921

Q34754667-27786D98-B1E6-4F43-B71F-372800DF76D7

Q34754667-311D479D-41BC-4D69-8B94-8AB716E675F5

P932

Q34754667-9D46B776-7822-40E4-9056-38E18BBF0138

P356

P1433

P1476

Molecular reorganization of endocannabinoid signalling in Alzheimer's disease

@en

P2093

Alán Alpár

http://www.w3.org/2001/XMLSchema#string

Ana M Martín-Moreno

http://www.w3.org/2001/XMLSchema#string

Heikki Tanila

http://www.w3.org/2001/XMLSchema#string

Masahiko Watanabe

http://www.w3.org/2001/XMLSchema#string

Susana J Pasquaré

http://www.w3.org/2001/XMLSchema#string

Tibor Harkany

http://www.w3.org/2001/XMLSchema#string

Tibor Hortobágyi

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer's Disease

Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain

Crystal structure of the human monoacylglycerol lipase, a key actor in endocannabinoid signaling

Brain monoglyceride lipase participating in endocannabinoid inactivation

Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects

The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors

A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol

Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

P304

1041-1060

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWR046

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 4

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P50

Attila Köfalvi

María L de Ceballos

Misha Zilberter

Samira G Ferreira

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50988774

http://www.w3.org/2001/XMLSchema#string

P698

21459826

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

endocannabinoids

P932

3069704

http://www.w3.org/2001/XMLSchema#string